Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases
MIDDLETOWN, Del., April 17, 2025 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi today announced that they have entered into a license agreement for two...
Japan Go IPO Summit Announces Roster of Expert Speakers for Event June 5th in Tokyo
Kura Sushi Executive to Deliver Keynote Address on Elements of Success for Cross-Border Listings TOKYO and NEW YORK, April 16, 2025 /PRNewswire/ -- The Japan Go IPO Summit , co-hosted by Nasdaq and MarcumAsia , is proud to announce an exceptional...
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China, April 9, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in patients with generalized...
Ditch the Pool Cover and Dive Into Spring Cleaning: Aiper Shares New Deals to Get Your Pool Summer-Ready
Aiper Announces Spring Deals Featuring Exclusive Discounts on Its All-New 2025 Line of Cordless Robotic Pool Cleaners and Skimmers ATLANTA, April 9, 2025 /PRNewswire/ -- From splashy cannonballs to poolside lounging, pool owners are counting down...
BeLive Holdings Announces Closing of Approximately $10,000,000 Initial Public Offering
SINGAPORE, April 8, 2025 /PRNewswire/ -- BeLive Holdings (the "Company" or "BeLive"), a provider of live commerce and shoppable short videos solutions ("BeLive Solutions") to international retail companies and e-commerce marketplaces, today...
Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor
SHANGHAI, April 2, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel B7-H3-targeting ADC (R&D code: 7MW3711) has been approved by the NMPA to enter Phase Ib/II...
So-Young International Inc. Announces Share Purchase by Controlling Shareholder
BEIJING, April 2, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that...
Mega Matrix Inc. Announces 2024 Year-End Financial Results
SINGAPORE, March 27, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), today announced year-end financial results for its fiscal year 2024 ended December 31, 2024. Financial Highlights In 2024, the Company's total...
CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress
Financial Performance: Strong Year-over-Year Improvemen t - Total Revenue: RMB 407.2 million, including RMB 232.1 million in licensing and royalty income. - Net Loss Reduction: 71.5% year-over-year improvement. Key Product Advancements - Sugemalimab...
DPC Dash Ltd Announces Full Year 2024 Financial Results
Revenues increased to RMB4.31 billion, representing 41.4% year-over-year growth Store-level operating profit grew by 48.7%; Adjusted group EBITDA increased by 64.1% Adjusted net profit reached RMB131.2 million, representing 1,394.2% year-over-year...